Skip to content

An fMRI and MRS based study to determine levels of different brain metabolites in Schizophrenia patients with persistent auditory verbal hallucinations.

Neurobiological Correlates of Persistent Auditory Hallucinations in Schizophrenia: An fMRI and MRS Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060245
Enrollment
48
Registered
2023-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Central Institute of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosis of Schizophrenia using Diagnostic Criteria for Research (DCR) of International Classification of Disease-10th edition (ICD-10 DCR, World Health Organization, 1993). 2.Age between 18- 60 years of either sex. 3.Minimum of 1 failed antipsychotic trial specified (minimum two weeks trial with chlorpromazine equivalents of >600 mg/day) and mean number of failed trials not reported. 4.A score >3 in the global rating of auditory hallucinations on the SAPS scale. 5.Right handed. 6.Patients giving written informed consent.

Exclusion criteria

Exclusion criteria: 1.Presence of co-morbid neurological or other psychiatric disorder(s). 2.Patient with co-morbid substance dependence, except nicotine and caffeine and having used the substance within 1 month of imaging. 3.Having any metallic implants/parts in body. 4.Subjects who have received ECT in past 6 months. 5.Patients having a history of head trauma with loss of consciousness.

Design outcomes

Primary

MeasureTime frame
1. difference in the levels of N-Acetyl Aspartate (NAA), N-Acetyl Aspartyl Glutamate (NAAG), Creatine + Phosphocreatine (Cr + PCr), Glycerophosphocholine + Phosphocholine (GPC + Pecha) and Myo-inositol (mI) in mPFC of schizophrenia patients with persistent Auditory-Verbal Hallucinations (pAVH) compared to healthy adults.Timepoint: Baseline

Secondary

MeasureTime frame
Difference in the resting-state functional connectivity of Default Mode Network between schizophrenia patients with pAVH & healthy controls.Timepoint: Baseline

Countries

India

Contacts

Public ContactDr Umesh S

Central Institute of Psychiatry

basudebdas@cipranchi.nic.in09431108544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026